TG Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	7,542	4,630	4,691	2,586	1,732	2,722
Market Cap Growth	28.28%	-1.30%	81.36%	49.35%	-36.37%	-62.78%
Enterprise Value	7,782	4,741	4,633	2,480	1,653	2,486
Last Close Price	53.22	29.81	30.10	17.08	11.83	19.00
PE Ratio	18.54	10.76	200.67	189.78	-	-
Forward PE	30.63	20.29	45.21	-	-	-
PS Ratio	10.77	7.51	14.26	11.07	621.81	406.90
PB Ratio	12.94	7.14	21.09	16.11	29.56	11.48
P/TBV Ratio	14.67	7.43	21.70	15.80	27.72	10.63
EV/Sales Ratio	11.11	7.69	14.08	10.61	593.58	371.66
EV/EBITDA Ratio	52.02	38.43	110.33	118.96	-	-
EV/EBIT Ratio	52.05	38.45	110.51	120.18	-	-
Debt / Equity Ratio	1.29	0.39	1.14	0.68	1.39	0.32
Debt / EBITDA Ratio	5.04	2.06	6.04	5.32	-	-
Net Debt / Equity Ratio	0.41	0.17	-0.26	-0.66	-1.34	-0.99
Net Debt / EBITDA Ratio	1.60	0.91	-1.36	-5.12	0.36	0.68
Net Debt / FCF Ratio	-16.85	-4.47	1.41	3.40	0.45	0.80
Asset Turnover	0.54	0.75	0.73	0.89	0.01	0.01
Inventory Turnover	0.93	0.85	0.51	0.71	-	-
Quick Ratio	4.84	2.91	4.85	5.00	3.04	4.84
Current Ratio	5.81	4.10	6.25	5.92	3.16	5.06
Return on Equity (ROE)	75.03%	102.75%	12.21%	11.57%	-151.36%	-92.03%
Return on Assets (ROA)	-20.50%	-32.53%	10.04%	8.12%	-76.17%	-68.59%
Return on Invested Capital (ROIC)	-32.42%	-54.18%	35.78%	47.49%	-541.49%	-635.09%
Return on Capital Employed (ROCE)	13.28%	17.66%	10.99%	9.91%	-96.04%	-80.90%
Earnings Yield	6.12%	9.29%	0.50%	0.53%	-	-
Buyback Yield / Dilution	2.27%	-0.67%	-7.96%	-9.67%	-2.41%	-14.64%
Total Shareholder Return	2.27%	-0.67%	-7.96%	-9.67%	-2.41%	-14.64%

SEC Filings: 10-K · 10-Q